Lecture Notes on the Placebo Effect and Internal Validity

The lecture focuses on the 'placebo effect', which is a crucial concept in understanding internal validity.
The placebo effect is the final topic in a series addressing threats to internal validity in experimental psychology.

Placebo Effect:
- The phenomenon where subjects experience improvements in their condition simply due to their expectation of improvement, rather than the actual efficacy of treatment.
- Example: Providing a patient with a fake drug (e.g., vitamin C) while telling them it's an effective painkiller (e.g., Tylenol) results in the patient feeling better if they believe in the treatment's effectiveness.

Behavior Under Influence of Placebo:
- Example of teenagers being given fake alcohol: They may exhibit behaviors associated with drunkenness despite not consuming actual alcohol.
- This demonstrates that the effect is real and not just an imagined improvement; subjects genuinely react as if they have received actual medication.
Mass Vaccination Reaction:
- In vaccination sites, the anxiety about vaccinations can lead individuals to experience adverse reactions like fainting or vomiting, which others may mimic, illustrating the social aspect of the placebo effect.

Depression Study Example:
- In a clinical trial, one group is administered an SSRI (selective serotonin reuptake inhibitor) while another receives a placebo.
- Both groups show improvement, but the SSRI group demonstrates a statistically significant improvement compared to the placebo group.
- Key Point: Just because there is improvement in the placebo group does not necessarily imply a placebo effect. Improvement may occur due to spontaneous recovery (maturation effect) or the history effect.
- Maturation Effect: Natural progression of conditions; individuals may improve over time without intervention.
- History Effect: External events or changes in circumstances that may contribute to the participants’ improvement aside from the treatment.

Importance of Control Groups:
- A control group that receives no treatment is necessary to properly assess the efficacy of an antidepressant and to understand the role of placebo effects in observed improvements.
- The expectation is that those receiving an antidepressant will show the most improvement, while the placebo group should improve more than the no-treatment group due to the placebo effect.
- Neglecting to include a control group can lead to erroneous conclusions about a treatment’s effectiveness.
Limitations of Placebo Use:
- Often pharmaceuticals are tested against a placebo rather than an inactive control group that receives nothing.
- The rationale is that if the drug does not prove to be more effective than a placebo, it may not be worth the risk of side effects from active medication.
- Understanding the ethical considerations surrounding the use of placebos, particularly the issue of informed consent, is important.
- In many jurisdictions, such as the U.S. and Canada, prescribing a placebo without patient awareness is prohibited, raising ethical concerns about consent and transparency.
- In some cultures, prescribing placebos without disclosure may be acceptable, creating a tension between ethical standards and clinical practice.

Critical Role of Experimental Design:
- Emphasizes the need for adequate experimental design to mitigate various threats to internal validity.
- Many internal validity threats can be addressed or prevented through the inclusion of a control group or a comparison group.
- Threats like regression to the mean and practice effects are only applicable in pretest-posttest designs, highlighting the importance of well-structured experimental setups.

Introduction of the next module (Module 12) which will cover experiments with multiple independent variables and interactions, building upon the concepts discussed in the current module about moderation effects.